跳至主要内容
临床试验/JPRN-UMIN000010922
JPRN-UMIN000010922招募中2 期

Randomized phase II study with S-1 (4week treatment and 2week rest) or S-1 (Alternate day administration) adjuvant chemotherapy for patients with pancreatic cancer - HORE PC01

HORE0 个研究点目标入组 70 人开始时间: 2013年6月11日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Prior history of S-1 therapy 2) Recurrent disease on enrollment 3) Massive ascites or pleural effusion 4) Plumonary fibrosis or interstitial pneumonia 5) Severe diarrhea 6) Severe infection 7) Blood transfusion within two weeks 8) Other severe complications such as heart failure, renal failure, liver failure, peptic ulcer, intestinal paralysis, etc 9) Severe mental disorder 10) Severe drug allergy 11) Other active malignancy 12) Pregnancy, breast feeding, or women who desire to preserve fecundity or Men who desire to have children 13) Regular use of frucitocin, fenitoin or warfarin 14) Inadequate physical condition, as diagnosed by primary physician

研究者

发起方
HORE

相似试验